Clincosm LogoSign in Get a demo

epithelial ovarian cancer

Showing 1 - 25 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian Cancer: A Retrospective Study

Recruiting
  • Epithelial Ovarian Cancer
  • Hematologic features
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
Oct 16, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Odense, Denmark
  • +3 more
Oct 16, 2023

Safety of Niraparib in Korean Primary and Recurrent Epithelial

Completed
  • Epithelial Ovarian Cancer
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023

Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Biological sample collection
  • Linz, Upper Austria, Austria
  • +2 more
Sep 28, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Epithelial Ovarian Cancer Trial (ROMA score evaluation)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • ROMA score evaluation
  • (no location specified)
Aug 7, 2023

The Immune Landscape of Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Collection of tumor samples, blood and vaginal and rectal swabs
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland
Aug 2, 2023

Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Acute Kidney Injury Due to Circulatory Failure
  • Sodium Sulfate
  • +2 more
  • (no location specified)
May 17, 2023

Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer

Active, not recruiting
  • Epithelial Ovarian Cancer
  • liquid biopsy
  • Aviano, Italy
    Centro di Riferimento Oncologico (CRO), IRCCS
May 16, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Medical Imaging in Gynecological Cancer (PRODIGYN)

Not yet recruiting
  • Cervix Cancer
  • +2 more
  • FDG-PET/CT and FDG-PET/MRI
  • (no location specified)
May 2, 2023

68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

Not yet recruiting
  • 68Ga-FAPI
  • +3 more
  • 68Ga-FAPI
  • Shanghai, Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
May 3, 2023

ctDNA Methylation for Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +7 more
  • CDO1 and HOXA9 methylation assay
  • Beijing, Beijing, China
    Lei Li
Mar 24, 2023

ctDNA Methylation for Detecting Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +8 more
  • Methylation assay
  • Beijing, Beijing, China
    Lei Li
Mar 24, 2023

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Epithelial Ovarian Cancer
  • AMG 794
  • Orange, California
    University of California at Irvine
Jan 25, 2023

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia Trial in Madison (Iron Sucrose)

Terminated
  • Epithelial Ovarian Cancer
  • +2 more
  • Iron Sucrose
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jan 3, 2023

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in France

Completed
  • Epithelial Ovarian Cancer
  • +2 more
    • Agen, France
    • +136 more
    Dec 12, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • Bengbu, Anhui, China
    • +27 more
    Nov 14, 2022

    Epithelial Ovarian Cancer, Triple Negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer Trial in Paris, Rennes, Milano

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • NI-1801
    • Paris, France
    • +4 more
    Nov 4, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine, Paclitaxel,

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • +3 more
    • Birmingham, Alabama
    • +207 more
    Oct 28, 2022